XML 59 R44.htm IDEA: XBRL DOCUMENT v3.24.2

Restructuring Costs and Similar Items (Tables)

6 Months Ended

Jun. 30, 2024

Analysis of income and expense [abstract]

Summary of Restructuring Costs and Similar Items

Restructuring costs and similar items comprise the following:

(€ million)			June 30, 2024 (6 months)			June 30, 2023 (6 months)						December 31, 2023 (12 months)
Employee-related expenses			849			185						489
Charges, gains or losses on assets(a)			(31)			86						293
Costs of transformation programs			347			265						676
Other restructuring costs			166			11						32
Total			1,331			547						1,490

(a) This line consists of impairment losses and accelerated depreciation charges related to site closures (including leased sites), and gains or losses on divestments of assets arising from reorganization decisions made by Sanofi.

X

- References

No definition available.

+ Details

Name:	ifrs-full_AnalysisOfIncomeAndExpenseAbstract
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of restructuring costs details.

+ References

No definition available.

+ Details

Name:	sny_DisclosureOfRestructuringCostsDetailsTableTextBlock
Namespace Prefix:	sny_
Data Type:	dtr-types1:textBlockItemType
Balance Type:	na
Period Type:	duration